<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Phytoestrogen consumption has been shown to reduce risk factors for <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> confers an adverse cardiovascular risk profile particularly in women after menopause </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to determine whether a <z:chebi fb="15" ids="50733">dietary supplement</z:chebi> with soy protein and <z:chebi fb="0" ids="18220">isoflavones</z:chebi> affected <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, glycemic control, and cardiovascular risk markers in postmenopausal women with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: A total of 32 postmenopausal women with diet-controlled type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> completed a randomized, double blind, cross-over trial of dietary supplementation with phytoestrogens (soy protein 30 g/day, <z:chebi fb="0" ids="18220">isoflavones</z:chebi> 132 mg/day) versus placebo (cellulose 30 g/day) for 12 weeks, separated by a 2-week washout period </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Compliance with the dietary supplementation was &gt;90% for both treatment phases </plain></SENT>
<SENT sid="5" pm="."><plain>When compared with the mean percentage change from baseline seen after 12 weeks of placebo, phytoestrogen supplementation demonstrated significantly lower mean values for fasting insulin (mean +/- SD 8.09 +/- 21.9%, P = 0.006), <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> (6.47 +/- 27.7%, P = 0.003), HbA(1c) (0.64 +/- 3.19%, P = 0.048), total cholesterol (4.07 +/- 8.13%, P = 0.004), <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> (7.09 +/- 12.7%, P = 0.001), cholesterol/<z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> ratio (3.89 +/- 11.7%, P = 0.015), and free <z:chebi fb="4" ids="30660">thyroxine</z:chebi> (2.50 +/- 8.47%, P = 0.004) </plain></SENT>
<SENT sid="6" pm="."><plain>No significant change occurred in <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi>, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, weight, blood pressure, <z:chebi fb="0" ids="16737">creatinine</z:chebi>, dehydroepiandrosterone <z:chebi fb="0" ids="16189">sulfate</z:chebi>, androstenedione, and the hypothalamic-pituitary-ovarian axis hormones </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: These results show that dietary supplementation with soy phytoestrogens favorably alters <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, glycemic control, and serum <z:chebi fb="2" ids="6495">lipoproteins</z:chebi> in postmenopausal women with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, thereby improving their cardiovascular risk profile </plain></SENT>
</text></document>